Moe, Orson W.

FGF23 induces left ventricular hypertrophy

Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation

Parathyroid Disorders and TreatmentsCardiac Fibrosis and Remodeling

Cited by 2,027

Disruption of the beclin 1–BCL2 autophagy regulatory complex promotes longevity in mice

Fernández, Á. F., Sebti, S., Wei, Y., Zou, Z., Shi, M., McMillan, K. L., He, C., Ting, T., Liu, Y., Chiang, W.-C., et al. (2018) · Nature

Genetics, Aging, and Longevity in Model OrganismsAutophagy in Disease and Therapy

Cited by 630

Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism

Hu, M. C., Shiizaki, K., Kuro-o, M., & Moe, O. W. (2013) · Annual Review of Physiology

Parathyroid Disorders and TreatmentsAlkaline Phosphatase Research Studies

Cited by 587

Rationale and design of the Kidney Precision Medicine Project

de Boer, I. H., Alpers, C. E., Azeloglu, E. U., Balis, U. G. J., Barasch, J. M., Barisoni, L., Blank, K. N., Bomback, A. S., Brown, K., Dagher, P. C., et al. (2021) · Kidney International

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 187

Biochemical and stone-risk profiles with topiramate treatment

Welch, B. J., Graybeal, D., Moe, O. W., Maalouf, N. M., & Sakhaee, K. (2006) · American Journal of Kidney Diseases

Kidney Stones and Urolithiasis TreatmentsGout, Hyperuricemia, Uric Acid

Cited by 126

Activation of dopamine D 1 -like receptors induces acute internalization of the renal Na + /phosphate cotransporter NaPi-IIa in mouse kidney and OK cells

Bacic, D., Capuano, P., Baum, M., Zhang, J., Stange, G., Biber, J., Kaissling, B., Moe, O. W., Wagner, C. A., & Murer, H. (2005) · American Journal of Physiology-Renal Physiology

Ion Transport and Channel RegulationParathyroid Disorders and Treatments

Cited by 76

Phosphate in Cardiovascular Disease: From New Insights Into Molecular Mechanisms to Clinical Implications

Turner, M. E., Beck, L., Hill Gallant, K. M., Chen, Y., Moe, O. W., Kuro-o, M., Moe, S. M., & Aikawa, E. (2024) · Arteriosclerosis, Thrombosis, and Vascular Biology

Parathyroid Disorders and TreatmentsAlkaline Phosphatase Research Studies

Cited by 54

High Phosphate Induces and Klotho Attenuates Kidney Epithelial Senescence and Fibrosis

Maique, J., Flores, B., Shi, M., Shepard, S., Zhou, Z., Yan, S., Moe, O. W., & Hu, M. C. (2020) · Frontiers in Pharmacology

Parathyroid Disorders and TreatmentsChronic Kidney Disease and Diabetes

Cited by 47

Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels

Gerber, J. S., Arroyo, E. M. P., Pastor, J., Correia, M., Rudloff, S., Moe, O. W., Egli-Spichtig, D., Mohebbi, N., & Wagner, C. A. (2025) · Pflügers Archiv - European Journal of Physiology

Parathyroid Disorders and TreatmentsBone health and osteoporosis research

Cited by 15

Association between dietary phosphate intake and skeletal muscle energetics in adults without cardiovascular disease

Giacona, J. M., Afridi, A., Bezan Petric, U., Johnson, T., Pastor, J., Ren, J., Sandon, L., Malloy, C., Pandey, A., Shah, A., et al. (2024) · Journal of Applied Physiology

Parathyroid Disorders and TreatmentsMuscle metabolism and nutrition

Cited by 10